work for patients with cancer is very complicated and not just limited to disease status and symptom burden,” she said. “You may need to consider how such factors interact with survivor characteristics such as age, sex, race, education, and marital
Search Results
Helping Cancer Survivors Return to Work
Presented by: Amye J. Tevaarwerk
Patient-Controlled Analgesia for Cancer-Related Pain: Clinical Predictors of Patient Outcomes
Emily J. Martin, Eric J. Roeland, Madison B. Sharp, Carolyn Revta, James D. Murphy, Katherine E. Fero, and Heidi N. Yeung
Edmonton Staging System for classifying cancer pain in advanced cancer patients . J Pain Symptom Manage 2005 ; 29 : 224 – 237 . 29. Mao JJ Armstrong K Bowman MA . Symptom burden among cancer survivors: impact of age and comorbidity . J Am
Primary Palliative Care Improves Uptake of Advance Care Planning Among Patients With Advanced Cancers
Michael G. Cohen, Andrew D. Althouse, Robert M. Arnold, Douglas White, Edward Chu, Margaret Rosenzweig, Kenneth J. Smith, and Yael Schenker
preceding or following their otherwise scheduled oncology appointment. As part of this training, nurses built shared care plans with patients, which included an assessment of symptom burden and goals of care. 17 At the first CONNECT visit, trained nurses
Targeted Agents: Management of Dermatologic Toxicities
Barbara Burtness
did those with higher grades of rash have an increase in skin symptoms, they also had an increase in emotional and functional impairment. The FAST-EGFRI is a patient-reported outcomes measure to assess the skin-related symptom burden and health
Improving Care Coordination to Optimize Health Outcomes in Cancer Survivors
Linda Overholser and Carlin Callaway
LD , Barbera L , Moody L , . Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes . J Clin Oncol 2018 ; 36 : 1103 – 1111 . 10.1200/JCO.2017.76.0876 29494259 3. Tamoxifen and uterine cancer
Updates in the Management of Myelofibrosis
Presented by: Andrew T. Kuykendall
risk status has been used as an inclusion criteria for most registrational clinical trials, Dr. Kuykendall argued that the treatment approach for this malignancy should hinge upon clinical presentation and symptom burden more so than risk. Treating
The Current State of Palliative Care for Patients Cared for at Leading US Cancer Centers: The 2015 NCCN Palliative Care Survey
Brook A. Calton, Amy Alvarez-Perez, Diane G. Portman, Kavitha J. Ramchandran, Jessica Sugalski, and Michael W. Rabow
particularly concerning in light of the severity of illness and symptom burden of the cancer population. Financial limitations are a major cause of constricted capacity. In a study of European cancer centers, Davis et al 26 cited key barriers to PC, including
Guiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Tool
Gabrielle B. Rocque, Richard A. Taylor, Aras Acemgil, Xuelin Li, Maria Pisu, Kelly Kenzik, Bradford E. Jackson, Karina I. Halilova, Wendy Demark-Wahnefried, Karen Meneses, Yufeng Li, Michelle Y. Martin, Carol Chambless, Nedra Lisovicz, Mona Fouad, Edward E. Partridge, Elizabeth A. Kvale, and the Patient Care Connect Group
being addressed by their physician. “New” and “chronic” sources of symptom burden were not distinguished in this study. It is possible that patients may be more likely to request assistance from the navigator on nonclinical issues, such as transportation
NCCN Guidelines Insights: Palliative Care, Version 2.2017
Maria Dans, Thomas Smith, Anthony Back, Justin N. Baker, Jessica R. Bauman, Anna C. Beck, Susan Block, Toby Campbell, Amy A. Case, Shalini Dalal, Howard Edwards, Thomas R. Fitch, Jennifer Kapo, Jean S. Kutner, Elizabeth Kvale, Charles Miller, Sumathi Misra, William Mitchell, Diane G. Portman, David Spiegel, Linda Sutton, Eytan Szmuilowicz, Jennifer Temel, Roma Tickoo, Susan G. Urba, Elizabeth Weinstein, Finly Zachariah, Mary Anne Bergman, and Jillian L. Scavone
frequency of hospitalization, and fewer intensive care unit (ICU) admissions and in-hospital deaths. 40 – 44 Palliative care has been shown to reduce symptom burden, improve QOL, and increase the odds of dying at home. Similarly, a 2013 Cochrane Database
Relationship Between Longitudinal Coping Strategies and Outcomes in Patients With Acute Myeloid Leukemia
Hermioni L. Amonoo, Elizabeth Daskalakis, Emma C. Deary, Monica H. Bodd, Matthew J. Reynolds, Ashley M. Nelson, Richard Newcomb, Tejaswini M. Dhawale, Daniel Yang, Selina M. Luger, Jillian L. Gustin, Andrew Brunner, Amir T. Fathi, Thomas W. LeBlanc, and Areej El-Jawahri
after an AML diagnosis include managing a prolonged 4- to 6-week hospitalization, disease and therapy complications (eg, infections), high symptom burden, and an uncertain prognosis. 1 , 3 , 4 In addition to the sizeable clinical burden, AML is
